US equity markets recorded positive gains in January due to improved consumer sentiment, strong manufacturing data and the Fed’s announcement that it will maintain exceptionally low rates through late 2014. In addition, China reported better-than-expected fourth-quarter growth, which climbed 8.9%. As such, the Dow Jones Industrial Average, S&P 500 and NASDAQ climbed 3.4%, 4.4% and […]
Seeking to solidify its position in the personalized health care market and add to its research instrument business, on January 25, Roche announced a $5.7 billion unsolicited proposal to acquire Illumina (see page 2). The announcement further bolstered expectations surrounding the use of post-Sanger sequencing, especially next-generation sequencing, in clinical and in vitro diagnostic (IVD) […]
Academic and Government Spending Concerns In 2011, concerns about cuts to the NIH budget and European governments’ research spending kept instrument and lab product companies on edge, affecting sales growth and operations, especially at life science companies. Uncertainty about budget changes froze spending at some US labs, while cutbacks affected labs in certain European countries. […]
To say that 2011 was a good year would be an understatement. Somewhat unexpectedly, 2011 results were much better than we could have hoped, given the strong rebound in 2010. So now is the time to look ahead to the coming year and the prospects for the analytical and life science instrument industry. Based on […]
This year proved to be difficult for lab product– and instrument-related IPOs (see table). The year’s largest debut was Fluidigm (see IBO 2/15/11). Jiangsu Skyray Instruments listed on the Shenzhen Stock Exchange’s ChiNext Market (see IBO 1/31/11), Microsaic Systems listed on the London Stock Exchange’s AIM Market (see IBO 4/15/11), and Norton Scientific debuted in […]
Company Announcements On October 15, Bernd Brust resigned as president of Molecular Medicine at Life Technologies. Illumina named Dr. Daniel S. Grosu, MD, to the newly created position of vice president and chief medical officer in late October. He was previously group director, Clinical Science, Clinical and Medical Affairs at Ortho-Clinical Diagnostics. On October 31, […]
Hong Kong 12/21/11; Hong Kong 12/30/11—Analytical instrument maker and distributor Techcomp began trading its shares on the Main Board of the Hong Kong Stock Exchange on December 21 (see IBO 3/31/11) through a transfer of existing shares. This is a dual listing for the company, whose shares also trade on the Singapore Stock Exchange. As […]
On December 23, President Obama signed into law an omnibus bill that will support the government for the rest of fiscal 2012. The final appropriations bill included funding for the NIH, the Department of Energy (DOE), the Centers for Disease Control and Prevention (CDC), the FDA and the EPA. Like the fiscal 2012 budgets for […]
Global equity markets slumped in 2011 with the exception of the US. The European sovereign debt crisis and natural disasters led the majority of Asia Pacific and European stock indexes down by double digits. US stock markets experienced similar volatility but ended the year with mixed results. Positive earnings reports lifted US equity prices in […]
Company Announcements CPI International named General Manager Jarrett Wendt president and CEO in October. In October, BioSurplus opened a sales office in Incheon, South Korea, in partnership with jDepot. In October, Agilent and the Agilent Technologies Foundation selected Steven Carr, PhD, who directs the Proteomics Platform at the Broad Institute of MIT and Harvard, for […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
